Get started
Author

Namrata Peswani

Observed name: N. Peswani
ORCID: 0009-0006-5918-1805
Observed ORCID: 0009-0006-5918-1805
OpenAlex ID: A5014371234
Abstract CT145: Olaparib +/- atezolizumab in patients with BRCA-mutated (BRCAmt) locally advanced unresectable or metastatic (advanced) breast cancer: an open-label, multicenter, randomized phase II trial
2023 · Kristina A. Fanucci, Mary Jo Pilat, et al. · Cancer Research · 19
Abstract RF3-05: A Phase 2 Study of Neoadjuvant HER2-targeted Therapy +/- Immunotherapy with Pembrolizumab (neoHIP)
2025 · Heather McArthur, Isaac Chan, et al. · Clinical Cancer Research · 7
CLONEVO: Preoperative abemaciclib for cisplatin-ineligible muscle-invasive bladder cancer (MIBC) with molecular response assessment.
2025 · Bishoy Morris Faltas, Mohamed Osman, et al. · Journal of Clinical Oncology · 4
PDF
Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0
2026 · Jennifer L. Caswell-Jin, Mark R. Somerfield, et al. · Journal of Clinical Oncology · 2
Abstract OT2-17-01: Phase 1 trial of anthracycline chemotherapy in combination with CD40 agonist and Flt3 ligand in metastatic triple-negative breast cancer
2023 · Sangeetha Reddy, Meredith Carter, et al. · Cancer Research · 2
Event-free survival from the randomized phase 2 neoHIP trial evaluating neoadjuvant taxane, HER2-targeted therapy, +/- pembrolizumab in early-stage HER2-positive breast cancer.
2026 · Heather L. McArthur, Stephanie Rice, et al. · Journal of Clinical Oncology · 1
Abstract PS5-08-28: Phase I pilot of pegylated liposomal doxorubicin, CD40 agonist antibody CDX-1140, and Flt3 ligand CDX-301 in advanced HER2-negative breast cancer
2026 · S. M. Reddy, C. A. Santa-Maria, et al. · Clinical Cancer Research
Abstract P3-12-30: Phase I trial of pegylated liposomal doxorubicin chemotherapy in combination with CD40 agonist and Flt3 ligand in metastatic HER2 negative breast cancer
2025 · Sangeetha Reddy, Cesar Santa-Maria, et al. · Clinical Cancer Research
Abstract CT127: Pre-operative abemaciclib in localized cisplatin-ineligible MIBC with tissue and ctDNA molecular response validation (CLONEVO)
2025 · Bishoy M. Faltas, Mohamed Osman, et al. · Cancer Research
Abstract PO5-19-08: Neoadjuvant HER2-targeted Therapy +/- Immunotherapy with Pembrolizumab (neoHIP): An Open Label Randomized Phase II Trial
2024 · Heather McArthur, Jorge Henrique Santos Leal, et al. · Cancer Research
Abstract PO1-19-08: Phase I trial of pegylated liposomal doxorubicin chemotherapy in combination with CD40 agonist and Flt3 ligand in metastatic triple-negative breast cancer
2024 · Sangeetha Reddy, Joyce O'Shaughnessy, et al. · Cancer Research
Works count: 11
Citation count: 35
H-index: 3
I10-index: 1
Year
Topic
Type